23 May 2013
13 April 1992
EUROPE: seemed to be impacted in many areas by elections of one sort or another. Despite earlier worries, FRANKFURT seemed...
13 April 1992
Concerns about economic evaluation of new drug products have been likened to the seven deadly sins by Michael Drummond of...
13 April 1992
Laboratoires Sobio, which is part of SmithKline Beecham, has launched a new 60mg oral formulation of Cervoxan (vinburnine) its cerebral/peripheral...
13 April 1992
The US pharmaceutical industry will continue to face growing resistance from the federal government and also from private forces towards...
13 April 1992
The Chilean pharmaceutical comp-any Silesia is continuing to expand at is base in Santiago. The company its currently working on...
13 April 1992
Hoffmann-La Roche has indicated that it expects to begin Phase III trials with its mono-amine oxidase type B-selective inhibitor lazabemide...
13 April 1992
Roche Produits, a subsidiary of Hoffmann-La Roche, has introduced its nail lacquer antifungal product Loceryl (amorolfine). This is the first...
13 April 1992
A safer treatment for traveller's diarrhea may soon be available, which will be suitable for use by adults, children and...
6 April 1992
Speaking at the 12th International Symposium on Intensive Care and Emergency Medicine in Brussels, late last month, Andre Heyns, Roussel-...
6 April 1992
Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...